4:58pm ET
Health and Healthcare
Will Increased Competition Hurt Gilead’s Outlook?
Gilead Sciences reported better-than-expected fourth-quarter results Tuesday after the markets closed.
Chris Lange
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 6:38am ET
GILD Coverage
Page 35 Chris Lange 12:20pm ET
Health and Healthcare
What to Expect From Gilead Earnings
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
8:56am ET
Investing
The Top 10 Corporate Earnings for the Week Ahead
24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming week.
11:00am ET
Health and Healthcare
Short Sellers Starting to Gang Up on Biotech
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
8:20am ET
Health and Healthcare
Merck Is Top DJIA Stock in 2015
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
8:55am ET
Health and Healthcare
Short Interest in Biotechs Signals Optimism
24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.
11:00am ET
Health and Healthcare
Gilead Continues to Recover from Express Scripts Loss
Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.
2:51pm ET
Health and Healthcare
Wells Fargo’s Top Biotech Stocks for 2015
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that…
10:35am ET
Health and Healthcare
Analyst’s 8 Top Health Care Stocks for 2015
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More
Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour and El Pollo Loco.
10:45am ET
Health and Healthcare
Is Gilead Already Coming Back Into Favor?
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More
Monday's top analyst upgrades, downgrades and initiations include Ambarella, Gilead Sciences, MarkWest Energy Partners, PNC Financial Services, Skyworks Solutions, RigNet and Sonus Networks.
12:15pm ET
Health and Healthcare
Analysts Predict Big Value Trap for Gilead Investors
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
1:20pm ET
Health and Healthcare
What the AbbVie and Express Script Deal Means for Gilead
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
10:00am ET
Health and Healthcare
Are Investors Signaling Optimism in Biotechs Through Short Interest?
The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top biotech companies.